Minorities more likely to view generic drugs as inferior, study finds

October 24, 2012 by Milly Dawson

Negative perceptions about generic drugs are more widespread among ethnic minorities than among whites, finds a new study in Ethnicity & Disease. Greater use of generic drugs, say the authors, could significantly reduce two major problems: patients' failing to take medications properly because they cannot afford brand name drugs and the amount spent overall on prescription medications.

"A lot of people can't afford their medicine. They end up in the ER for something preventable," said Anthony Omojasola, DrPH, the study's lead author. "We wanted to see if people were aware of generic drug discount programs and, if they were aware, why they would or would not participate."

Discount programs offered by retailers such as Wal-Mart offer many common generic drugs for $4 for a 30-day supply. The authors add that most doctors seldom ask about problems paying for prescriptions and patients seldom raise such problems with physicians.

The study results come from a survey of Houston residents with incomes under $30,000 with a chronic condition requiring a prescription drug or a family member with such a condition.  Most respondents were female (77 percent) and African-American (67 percent).

The researchers found no significant differences by race/ethnicity in the use of generic drug discount programs. About 75 percent of survey participants agreed that generics are "equal in quality" to, just "as safe as" and "just as effective as" name drugs. However, negative perceptions about the potential for side effects and about "inferiority" of generics compared to brand name drugs were more pronounced among minority group members than among white participants.

Compared to non-Hispanic whites, blacks and Hispanics were 10 times as likely to agree that generic drugs had more side effects than brand name ones. They were also 4 times as likely as whites to agree that generics were inferior to brand name drugs. Still, did not prevent minorities from using generic drugs.

Gerard Anderson, Ph.D. of Johns Hopkins School of Public Health commented that while generic drugs are therapeutically equivalent to brand name drugs, patients often lack this information; generic drug companies don't advertise like companies promoting brand name drugs.

Anderson added the fact that minorities are more suspicious of is not so surprising, he said, "What is more surprising is that in spite of this suspicion they are willing to participate in generic substitution programs."

Omojasola's team called for physicians and pharmacists to better educate patients about the general equivalency of generic and brand name drugs to reduce concerns about generic substitutions and medication costs for patients and society.

Explore further: Americans turn to generic medications in 2010: report

More information: A. Omojasola, DrPH; M. Hernandez, MS; S. Sansgiry, PhD; L. Jones, Ph.D., Perception of Generic Prescription Drugs And Utilization Of Generic Drug Discount Programs, Ethnicity & Disease, Volume 22, Autumn 2012.

Related Stories

Americans turn to generic medications in 2010: report

April 22, 2011
(Medical Xpress) -- In a new report released by the IMS Institute for Healthcare Informatics, the results show that over 78% of the almost four billion prescriptions written in the U.S. in 2010 were for generic drugs. The ...

Variation in make-up of generic epilepsy drugs can lead to dosing problems

June 30, 2011
Generic anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may not be effective, particularly ...

No difference in brand name and generic drugs regarding thyroid dysfunction

July 11, 2011
There is no difference between brand-name and generic drug formulations of amiodarone -- taken to control arrhythmia – in the incidence of thyroid dysfunction, according to a study in CMAJ (Canadian Medical Association ...

Substitution of brand name with generic drug proves safe for transplant recipients

September 13, 2011
A new study published in the American Journal of Transplantation reveals that substitution of a brand name immunosuppressive drug with a generic (manufactured by Sandoz) for preventing rejection of transplanted organs appears ...

Recommended for you

Sensor-equipped pill raises technological, ethical questions

November 17, 2017
The first drug with a sensor embedded in a pill that alerts doctors when patients have taken their medications was approved by the Food and Drug Administration, raiding issues involving privacy, cost, and whether patients ...

New painkillers reduce overdose risk

November 16, 2017
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have developed new opioid pain relievers that reduce pain on par with morphine but do not slow or stop breathing—the cause of opiate overdose.

Separating side effects could hold key for safer opioids

November 16, 2017
Opioid pain relievers can be extremely effective in relieving pain, but can carry a high risk of addiction and ultimately overdose when breathing is suppressed and stops. Scientists have discovered a way to separate these ...

US regulators approve first digital pill to track patients

November 14, 2017
U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

Introduction is different, but top medications for opioid addiction equally effective

November 14, 2017
With opioid addiction officially declared a public health emergency in the U.S., medical intervention to treat the illness is increasingly important in responding to the epidemic. Now, a new study concludes that two of the ...

Drugstore pain pills as effective as opioids in ER patients

November 7, 2017
Emergency rooms are where many patients are first introduced to powerful opioid painkillers, but what if doctors offered over-the-counter pills instead? A new study tested that approach on patients with broken bones and sprains ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.